PACS Group, Inc. saw a drop in stock value due to the delay in releasing third-quarter results and federal investigations. The company showed strong facility occupancy rates and expanded operations, but faces scrutiny for allegedly exploiting healthcare programs. CEO Jason Murray addressed the allegations and confirmed cooperation with government investigations.